4
Changes in Ownership
Iambic Therapeutics, Inc. Filed Acc 0001855980-26-000009
CFO & Chief Corp Dev Ofcr acquired 61,342 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Secora Michael CFO & Chief Corp Dev Ofcr | 2026-10-16 | Conversion | +61,342 | 279,902 | D | ||
| Derivatives | |||||||
| Secora Michael CFO & Chief Corp Dev Ofcr | 2026-10-16 | Conversion · Series B-3 Convertible Preferred Stock | −61,342 | 0 | D | ||
Loading xslF345X06/form4-10192026_111033.xml…